Cibinqo (abrocitinib)

pCPA File Number: 21987
Negotiation Status:
Under consideration for negotiation
Indication(s):
moderate to severe atopic dermatitis
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
SR0686
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable